6505NCM239271: ROPIVACAINE HCL INJECTION.
The ROPIVACAINE HCL INJECTION is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: ROPIVACAINE HCL INJECTION, USP. 0.5% 150 MG PER 30 ML SINGLE-DOSE VIALS, 25EA.
This part is cataloged in the U.S. Government catalog under NSN 6505-01-713-8055, indicating validated use in U.S. government and defense logistics supply chains.
Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | ROPIVACAINE HCL INJECTION, USP. 0.5% 150 MG PER 30 ML SINGLE-DOSE VIALS, 25EA |
| NSN | 6505-01-713-8055 |
| SPECIAL FEATURES | ROPIVACAINE HCL INJECTION, USP. 0.5% 150 MG PER 30 ML SINGLE-DOSE VIALS,25CT. FOR INFILTRATION, NERVE BLOCK, AND EPIDURAL ADMINISTRATION ONLY. NOT FOR INTRAVENOUS ADMINISTRATION.STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE). |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ROPIVACAINE HCL INJECTION, USP. 0.5% 150 MG PER 30 ML SINGLE-DOSE VIALS, 25EA |